A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Phase of Trial: Phase III
Latest Information Update: 27 Dec 2018
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Enterovirus infections; Rhinorrhoea; Rhinovirus infections
- Focus Registrational; Therapeutic Use
- Sponsors Romark Laboratories
- 17 Dec 2018 Planned number of patients changed from 1200 to 1750.
- 28 Sep 2018 Status changed from not yet recruiting to recruiting.
- 03 Aug 2018 New trial record